For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...
The Food and Drug Administration has issued a Class II recall for certain International Delight coffee creamers after reports ...
The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...
The Tryvio REMS program was established due to the risk of birth defects associated with the ERA drug class. Prior to dispensing Tryvio, patients of reproductive potential were required to report a ...
Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström ...
Bexobrutideg, a bioavailable agent, was granted orphan drug designation by the FDA for Waldenström macroglobulinemia, a type ...
The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...
PEP-Therapy is a Paris-based clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, lead drug candidate, is a pro-apoptotic agent currently ...
Seafood chowder and a pet food product have been recalled over risk of serious illness and bird flu contamination, ...
The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...
Two flavors of International Delight coffee creamer have been voluntarily recalled after reports of illness and "spoilage." ...
Over 75,000 bottles of International Delight coffee creamer have been recalled due to spoilage and illness reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback